Rate My Professor Gil Wolfe

Gil I. Wolfe, MD, FAAN, is a SUNY Distinguished Professor of Neurology at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, where he directs the Neuromuscular Medicine program and serves as Chief of Neurology Service at Kaleida Health. He previously held the position of Irvin and Rosemary Smith Professor and Chair of the Department of Neurology from 2012 to July 2024. Wolfe earned a BA in Biology from Princeton University in 1985, graduating cum laude, and an MD from the University of Texas Southwestern Medical School in 1989. He completed an internship in internal medicine, residency in neurology, and fellowship in neuromuscular disease at the University of Pennsylvania between 1989 and 1994. Prior to joining UB, he was Professor of Neurology at UT Southwestern from 1994 to 2011, where he held the Dr. Bob and Jean Smith Foundation Distinguished Chair in Neuromuscular Disease Research, co-directed Muscular Dystrophy Association clinics, and led the Myasthenia Gravis and Peripheral Neuropathy clinics.

Board-certified in neurology, neuromuscular medicine, and neurophysiology, Wolfe specializes in neuromuscular disorders, including idiopathic and immune-mediated peripheral neuropathies and myasthenia gravis. He performs electromyography, nerve conduction studies, and intraoperative monitoring. His research has been funded by the NIH, Muscular Dystrophy Association, and Myasthenia Gravis Foundation of America. Key publications include the landmark randomized trial of thymectomy in myasthenia gravis published in the New England Journal of Medicine (2016), a 2025 NEJM editorial on B-cell depletion therapies titled “Myasthenia Gravis — Redemption for B-Cell Depletion,” and contributions to international myasthenia gravis guidelines. Wolfe has received numerous honors, including UB Distinguished Professor (2017), SUNY Distinguished Professor (2022), Chancellor's Award for Excellence in Scholarship and Creative Activities (2018), and Doctor of the Year from the Myasthenia Gravis Foundation of America (2015). He served as President of the New York State Neurological Society (2018-2020) and co-chaired panels revising myasthenia gravis guidelines. Actively involved in physician training, he has directed fellowships and residency programs.